Recent Advances in Acne Vulgaris Research: Insights and Clinical Implications

Advances in Dermatology

Volumn 24, Issue C, 2008, Pages 197-209

  Wang, Kevin C ^a   Zane, Lee T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; HUMAN; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW;

ACNE VULGARIS; HUMANS; QUALITY OF LIFE;

EID: 56349156136     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yadr.2008.09.002     Document Type: Review

References (70)

1. Fulton Jr. J.E., Plewig G., and Kligman A.M. Effect of chocolate on acne vulgaris. JAMA 210 11 (1969) 2071-2074
2. Anderson P.C. Foods as the cause of acne. Am Fam Physician 3 3 (1971) 102-103
3. Cordain L., Lindeberg S., Hurtado M., et al. Acne vulgaris: a disease of western civilization. Arch Dermatol 138 12 (2002) 1584-1590
4. Adebamowo C.A., Spiegelman D., Berkey C.S., et al. Milk consumption and acne in adolescent girls. Dermatol Online J 12 4 (2006) 1. http://dermatology.cdlib.org/124/original/acne/danby.html Accessed September 22, 2008
5. Smith R.N., Mann N.J., Braue A., et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 57 2 (2007) 247-256
6. Frost G., Keogh B., Smith D., et al. The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 45 6 (1996) 669-672
7. Aizawa H., and Niimura M. Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne. J Dermatol 23 8 (1996) 526-529
8. Strauss J.S., Kligman A.M., and Pochi P.E. The effect of androgens and estrogens on human sebaceous glands. J Invest Dermatol 39 (1962) 139-155
9. Deplewski D., and Rosenfield R.L. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140 9 (1999) 4089-4094
10. Cappel M., Mauger D., and Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 141 3 (2005) 333-338
11. Kiddy D.S., Hamilton-Fairley D., Seppala M., et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 31 6 (1989) 757-763
12. Shaw J.C. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol 3 8 (2002) 571-578
13. Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 22 5 (2004) 419-428
14. Zouboulis C.C., and Degitz K. Androgen action on human skin: from basic research to clinical significance. Exp Dermatol 13 Suppl 4 (2004) 5-10
15. Fritsch M., Orfanos C.E., and Zouboulis C.C. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol 116 5 (2001) 793-800
16. Guy R., Ridden C., and Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Invest Dermatol 106 3 (1996) 454-460
17. Thiboutot D.M., Knaggs H., Gilliland K., et al. Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 136 2 (1997) 166-171
18. Zouboulis C.C., Seltmann H., Hiroi N., et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 99 10 (2002) 7148-7153
19. Thornton M.J. The biological actions of estrogens on skin. Exp Dermatol 11 6 (2002) 487-502
20. Gustafsson J.A. An update on estrogen receptors. Semin Perinatol 24 1 (2000) 66-69
21. Plewig G., and Kligman A.M. Acne and rosacea. 3rd edition (2003), Springer, Berlin
22. Mempel M., Kalali B.N., Ollert M., et al. Toll-like receptors in dermatology. Dermatol Clin 25 4 (2007) 531-540 viii
23. Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211 3 (2005) 193-198
24. Bialecka A., Mak M., Biedron R., et al. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne. Arch Immunol Ther Exp (Warsz) 53 1 (2005) 79-85
25. Wong D.J., and Chang H.Y. Learning more from microarrays: insights from modules and networks. J Invest Dermatol 125 2 (2005) 175-182
26. Papakonstantinou E., Aletras A.J., Glass E., et al. Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin. J Invest Dermatol 125 4 (2005) 673-684
27. Trivedi N.R., Gilliland K.L., Zhao W., et al. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 126 5 (2006) 1071-1079
28. Chakraborti S., Mandal M., Das S., et al. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253 1-2 (2003) 269-285
29. Lee A.T., and Zane L.T. Dermatologic manifestations of polycystic ovary syndrome. Am J Clin Dermatol 8 4 (2007) 201-219
30. Norman R.J., Dewailly D., Legro R.S., et al. Polycystic ovary syndrome. Lancet 370 9588 (2007) 685-697
31. Azziz R., Sanchez L.A., Knochenhauer E.S., et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89 2 (2004) 453-462
32. Pugeat M., Ducluzeau P.H., and Mallion-Donadieu M. Association of insulin resistance with hyperandrogenia in women. Horm Res 54 5-6 (2000) 322-326
33. Deplewski D., and Rosenfield R.L. Role of hormones in pilosebaceous unit development. Endocr Rev 21 4 (2000) 363-392
34. Tallon B., and Corkill M. Peculiarities of PAPA syndrome. Rheumatology (Oxford) 45 9 (2006) 1140-1143
35. Galeazzi M., Gasbarrini G., Ghirardello A., et al. Autoinflammatory syndromes. Clin Exp Rheumatol 24 1 Suppl 40 (2006) S79-S85
36. Wise C.A., Gillum J.D., Seidman C.E., et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11 8 (2002) 961-969
37. Inohara N., and Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3 5 (2003) 371-382
38. Dierselhuis M.P., Frenkel J., Wulffraat N.M., et al. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford) 44 3 (2005) 406-408
39. Stichweh D.S., Punaro M., and Pascual V. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22 3 (2005) 262-265
40. Beretta-Piccoli B.C., Sauvain M.J., Gal I., et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 159 8 (2000) 594-601
41. Hayem G., Bouchaud-Chabot A., Benali K., et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 29 3 (1999) 159-171
42. Kotilainen P., Merilahti-Palo R., Lehtonen O.P., et al. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 23 7 (1996) 1302-1304
43. Eady E.A., Cove J.H., Holland K.T., et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 121 1 (1989) 51-57
44. Ozolins M., Eady E.A., Avery A.J., et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 364 9452 (2004) 2188-2195
45. Zane L.T. Acne maintenance therapy: expanding the role of topical retinoids?. Arch Dermatol 142 5 (2006) 638-640
46. Ross J.I., Snelling A.M., Eady E.A., et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 144 2 (2001) 339-346
47. Dreno B., Bettoli V., Ochsendorf F., et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 14 6 (2004) 391-399
48. Leyden J.J., Del Rosso J.Q., and Webster G.F. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis 79 6 Suppl (2007) 9-25
49. Gollnick H., Cunliffe W., Berson D., et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 49 1 Suppl (2003) S1-S37
50. Thiboutot D.M., Shalita A.R., Yamauchi P.S., et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 142 5 (2006) 597-602
51. Leyden J., Thiboutot D.M., Shalita A.R., et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 142 5 (2006) 605-612
52. Harper J.C., and Thiboutot D.M. Pathogenesis of acne: recent research advances. Adv Dermatol 19 (2003) 1-10
53. Nelson A.M., Gilliland K.L., Cong Z., et al. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol 126 10 (2006) 2178-2189
54. Wozel G., Chang A., Zultak M., et al. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin. Arch Dermatol Res 283 3 (1991) 158-161
55. Liu P.T., Krutzik S.R., Kim J., et al. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol 174 5 (2005) 2467-2470
56. Tenaud I., Khammari A., and Dreno B. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 16 6 (2007) 500-506
57. Gill T.M., and Feinstein A.R. A critical appraisal of the quality of quality-of-life measurements. JAMA 272 8 (1994) 619-626
58. Dreno B. Assessing quality of life in patients with acne vulgaris: implications for treatment. Am J Clin Dermatol 7 2 (2006) 99-106
59. Chren M.M., Lasek R.J., Quinn L.M., et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 107 5 (1996) 707-713
60. Finlay A.Y., and Khan G.K. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 19 3 (1994) 210-216
61. Girman C.J., Hartmaier S., Thiboutot D., et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 5 5 (1996) 481-490
62. Martin A.R., Lookingbill D.P., Botek A., et al. Health-related quality of life among patients with facial acne: assessment of a new acne-specific questionnaire. Clin Exp Dermatol 26 5 (2001) 380-385
63. Gupta M.A., Johnson A.M., and Gupta A.K. The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 78 6 (1998) 451-456
64. Nease Jr. R.F., Kneeland T., O'Connor G.T., et al. Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines. Ischemic heart disease patient outcomes research team. JAMA 273 15 (1995) 1185-1190
65. Goldstein M., and Tsevat J. Applying utility assessment at the bedside. In: Chapman G.B., and Sonnenberg F.A. (Eds). Decision making in health care: theory, psychology, and applications (2000), Cambridge University Press, Cambridge (MA): 313-333
66. Chen S.C., Bayoumi A.M., Soon S.L., et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc 9 2 (2004) 160-168
67. Mittmann N., Trakas K., Risebrough N., et al. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 15 4 (1999) 369-376
68. Chen C.L., Kuppermann M., Caughey A.B., et al. A community-based study of acne-related health preferences in adolescents. Arch Dermatol 144 8 (2008) 988-994
69. Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res 29 3 (1998) 201-209
70. Saw S.M., Gazzard G., Au Eong K.G., et al. Utility values and myopia in teenage school students. Br J Ophthalmol 87 3 (2003) 341-345